Dependencies |
Module Recommendations
This is prior learning (or a practical skill) that is strongly recommended before enrolment in this module. You may enrol in this module if you have not acquired the recommended learning but you will have considerable difficulty in passing (i.e. achieving the learning outcomes of) the module. While the prior learning is expressed as named MTU module(s) it also allows for learning (in another module or modules) which is equivalent to the learning specified in the named module(s).
|
9446 |
MGMT6021 |
cGMP 1 & Quality Assurance |
Incompatible Modules
These are modules which have learning outcomes that are too similar to the learning outcomes of this module. You may not earn additional credit for the same learning and therefore you may not enrol in this module if you have successfully completed any modules in the incompatible list.
|
No incompatible modules listed |
Co-requisite Modules
|
No Co-requisite modules listed |
Requirements
This is prior learning (or a practical skill) that is mandatory before enrolment in this module is allowed. You may not enrol on this module if you have not acquired the learning specified in this section.
|
None |
Indicative Content |
Current topics
Overview of events such as the Thalidomide disaster and the Transmissible Spongiform Encephalopathy crisis and their impact on regulation. Globalisation of the pharmaceutical and medical device sectors, implications for control of the industries. Counterfeiting. Patents. Orphan Medicines. Generics and biosimilars. Purchasing medicines online. Review of current issues.
|
Product Authorisation
Steps in the approval of medicines and medical devices. Licencing of patented medicines, generic medicines and biosimilars.
|
GMP Regulations and Guidelines
Review of EU and FDA directives, regulations and guidelines on the control of medicine or medical device manufacture. Function of the International Conference on Harmonisation (ICH) or International Medical Device Regulators Forum. Review of recent recalls and warning letters. Introduction to validation.
|
Quality Control
Role of Quality Control, implementation of GMP regulations in QC (appropriate documention, auditing, training etc.). Pharmacopoeia.
Sampling, OC curves, sampling plans, sampling tables. Review of commonly used QC tests. Retain samples. Stability programmes.
Managing Quality: testing pathway, sample storage. Out of Specification (OOS) Investigations. Laboratory Information Management Systems. Process Analytical Technology. Quality reviews.
|
The University reserves the right to alter the nature and timings of assessment
Module Resources
|
Recommended Book Resources |
---|
-
MHRA. (2013), Rules and Compliance for Pharmaceutical Manufacturers and Distributors, Pharmaceutical Press, [ISBN: -10: 0857111027].
-
Burgess C. (2000), Valid Analytical Methods and Procedures, Cambridge: Royal Society of Chemistry, [ISBN: 0854044825].
-
WHO. (2006), International Pharmacopoeia, 4th. [ISBN: 2 VOLUMES: 924156301X - 9789241563017].
|
Supplementary Book Resources |
---|
-
Robert A. Nash, Alfred H Wachter, Marcel Dekker. (2003), Pharmaceutical Process Validation, [ISBN: 0-8247-0838-5].
|
This module does not have any article/paper resources |
---|
Other Resources |
---|
-
Hard or Soft Copy, Course Notes.
-
Website, Food and Drug Administration. www.fda.gov.
-
Website, European Medicines Agency.
-
Website, Health Products Regulatory Authority. www.hpra.ie.
-
Website, International Conference on
Harmonisation. www.ich.org.
-
Website, International Medical Device Regulators
Forum.
-
Website, Irish Business and Employers
Confederation. www.ibec.ie.
|